Nikolas K. Haass

Citované v

	Všetky	Od 2020
Citácie	8887	3403
h-index	46	34
i10-index	86	77

800

400

200

600

20052006200720082009201020112012201320142015201620172018201920202021202220232024202539 83 106 151 259 297 393 399 492 467 505 472 544 545 608 791 753 663 565 549 80

Verejný prístup

všetky položky

63 článkov

6 článkov

dostupné

nedostupné

Na základe mandátov na financovanie

Spoluautori

Helmut SchaiderThe University of QueenslandOverená e-mailová adresa na: uq.edu.au
Nethia Mohana KumaranSenior Lecturer, School of Biological Sciences, Universiti Sains MalaysiaOverená e-mailová adresa na: usm.my
DINOOP RAVINDRAN MENONUniversity of Colorado Denver, Anshutz Medical campusOverená e-mailová adresa na: cuanschutz.edu
Peter HerseyOverená e-mailová adresa na: sydney.edu.au
Clemens KreplerMerck& CoOverená e-mailová adresa na: merck.com
Peter GunningUniversity of New South WalesOverená e-mailová adresa na: unsw.edu.au
Mitchell FanePostdoctoral Fellow, Johns Hopkins School of Public HealthOverená e-mailová adresa na: jhu.edu
Adam McCluskeyUniversity of NewcastleOverená e-mailová adresa na: newcastle.edu.au
Shweta TikooMedical University of ViennaOverená e-mailová adresa na: meduniwien.ac.at
Richard A ScolyerMelanoma Institute Australia, The University of Sydney, Royal Prince Alfred HospitalOverená e-mailová adresa na: sswahs.nsw.gov.au
Katherine L NathansonProfessor of Medicine, Perelman School of Medicine at the University of PennsylvaniaOverená e-mailová adresa na: upenn.edu
Galina SchevzovResearch FellowOverená e-mailová adresa na: unsw.edu.au
Herbert TreutleinSanoosa Pty. Ltd.Overená e-mailová adresa na: sanoosa.com
Soyer HPChair in Dermatology, The University of Queensland, Frazer InstituteOverená e-mailová adresa na: uq.edu.au
Xu Dong ZhangProfessor, School of Medicine and Public Health, University of Newcastle, AustraliaOverená e-mailová adresa na: newcastle.edu.au
yazi keOverená e-mailová adresa na: mq.edu.au
Eric MeggersProfessor of Chemistry, Philipps University Marburg (Germany)Overená e-mailová adresa na: chemie.uni-marburg.de
Amadeus GladbachUNSW AustraliaOverená e-mailová adresa na: unsw.edu.au
Thomas FathProfessor, Macquarie UniversityOverená e-mailová adresa na: mq.edu.au
Stuart GallagherSenior Research Officer, Centenary Institute, Sydney. Melanoma Institute of Australia. University ofOverená e-mailová adresa na: sydney.edu.au

Sledovať

Nikolas K. Haass

Professor for Cutaneous Oncology

Overená e-mailová adresa na: uq.edu.au

Cutaneous Oncology


Názov Zoradiť podľa citácií Zoradiť podľa roka Zoradiť podľa názvu	Citované v Citované v	Rok
Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activity J Tsai, JT Lee, W Wang, J Zhang, H Cho, S Mamo, R Bremer, S Gillette, ... Proceedings of the National Academy of Sciences 105 (8), 3041-3046, 2008	1646	2008
Multiple signaling pathways must be targeted to overcome drug resistance in cell lines derived from melanoma metastases KSM Smalley, NK Haass, PA Brafford, M Lioni, KT Flaherty, M Herlyn Molecular cancer therapeutics 5 (5), 1136-1144, 2006	528	2006
Adhesion, migration and communication in melanocytes and melanoma NK Haass, KSM Smalley, L Li, M Herlyn Pigment cell research 18 (3), 150-159, 2005	521	2005
Normal human melanocyte homeostasis as a paradigm for understanding melanoma NK Haass, M Herlyn Journal of Investigative Dermatology Symposium Proceedings 10 (2), 153-163, 2005	295	2005
An organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells KSM Smalley, R Contractor, NK Haass, AN Kulp, GE Atilla-Gokcumen, ... Cancer research 67 (1), 209-217, 2007	280	2007
The mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitor AZD6244 (ARRY-142886) induces growth arrest in melanoma cells and tumor regression when … NK Haass, K Sproesser, TK Nguyen, R Contractor, CA Medina, ... Clinical Cancer Research 14 (1), 230-239, 2008	272	2008
Targeting glutamine transport to suppress melanoma cell growth Q Wang, KA Beaumont, NJ Otte, J Font, CG Bailey, M van Geldermalsen, ... International journal of cancer 135 (5), 1060-1071, 2014	255	2014
The role of altered cell–cell communication in melanoma progression NK Haass, KSM Smalley, M Herlyn Journal of molecular histology 35, 309-318, 2004	232	2004
A novel class of anticancer compounds targets the actin cytoskeleton in tumor cells JR Stehn, NK Haass, T Bonello, M Desouza, G Kottyan, H Treutlein, ... Cancer research 73 (16), 5169-5182, 2013	207	2013
PLX4032, a potent inhibitor of the B‐Raf V600E oncogene, selectively inhibits V600E‐positive melanomas JT Lee, L Li, PA Brafford, M Van Den Eijnden, MB Halloran, K Sproesser, ... Pigment cell & melanoma research 23 (6), 820-827, 2010	202	2010
Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion KSM Smalley, P Brafford, NK Haass, JM Brandner, E Brown, M Herlyn The American journal of pathology 166 (5), 1541-1554, 2005	192	2005
BCL-XL and MCL-1 are the key BCL-2 family proteins in melanoma cell survival EF Lee, TJ Harris, S Tran, M Evangelista, S Arulananda, T John, ... Cell death & disease 10 (5), 342, 2019	181	2019
Detection of primary melanoma in individuals at extreme high risk: a prospective 5-year follow-up study FJ Moloney, P Guitera, E Coates, NK Haass, K Ho, R Khoury, ... JAMA dermatology 150 (8), 819-827, 2014	159	2014
Microenvironment-driven dynamic heterogeneity and phenotypic plasticity as a mechanism of melanoma therapy resistance F Ahmed, NK Haass Frontiers in oncology 8, 173, 2018	154	2018
In vitro three-dimensional tumor microenvironment models for anticancer drug discovery KSM Smalley, M Lioni, K Noma, NK Haass, M Herlyn Expert opinion on drug discovery 3 (1), 1-10, 2008	149	2008
A stress-induced early innate response causes multidrug tolerance in melanoma D Ravindran Menon, S Das, C Krepler, A Vultur, B Rinner, S Schauer, ... Oncogene 34 (34), 4448-4459, 2015	144	2015
Real‐time cell cycle imaging during melanoma growth, invasion, and drug response NK Haass, KA Beaumont, DS Hill, A Anfosso, P Mrass, MA Munoz, ... Pigment cell & melanoma research 27 (5), 764-776, 2014	143	2014
Modeling Melanoma In Vitro and In Vivo KA Beaumont, N Mohana-Kumaran, NK Haass Healthcare 2 (1), 27-46, 2013	136	2013
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737 KM Lucas, N Mohana-Kumaran, D Lau, XD Zhang, P Hersey, DC Huang, ... Clinical cancer research 18 (3), 783-795, 2012	125	2012
Ki67 expression levels are a better marker of reduced melanoma growth following MEK inhibitor treatment than phospho-ERK levels KSM Smalley, R Contractor, NK Haass, JT Lee, KL Nathanson, ... British journal of cancer 96 (3), 445-449, 2007	107	2007

Systém momentálne nemôže vykonať operáciu. Skúste to neskôr.

Články 1–20

Citácie za rok

Duplicitné citácie

Zlúčené citácie

Pridať spoluautorovSpoluautori

Sledovať

Citované v

Spoluautori